Catalyst Pharmaceuticals (CPRX) Shareholder's Equity Growth (1y) (2011 - 2026)
Catalyst Pharmaceuticals (CPRX) Shareholder's Equity Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Catalyst Pharmaceuticals |
3.84 Bn |
3.08 Bn |
134.92 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
27.50% |
| Dec 31, 2025 |
31.15% |
| Sep 30, 2025 |
39.23% |
| Jun 30, 2025 |
40.64% |
| Mar 31, 2025 |
41.48% |
| Dec 31, 2024 |
87.59% |
| Sep 30, 2024 |
89.63% |
| Jun 30, 2024 |
62.18% |
| Mar 31, 2024 |
68.26% |
| Dec 31, 2023 |
29.11% |
| Sep 30, 2023 |
29.07% |
| Jun 30, 2023 |
55.66% |
| Mar 31, 2023 |
51.51% |
| Dec 31, 2022 |
45.25% |
| Sep 30, 2022 |
35.93% |
| Jun 30, 2022 |
27.60% |
| Mar 31, 2022 |
23.27% |
| Dec 31, 2021 |
21.95% |
| Sep 30, 2021 |
26.84% |
| Jun 30, 2021 |
69.91% |
